/Companies

Caris Life Sciences

NASDAQ: CAIUnicorn · $5.3B

Founded 1996 · Incorporated in Texas · 1,723 employees on LinkedIn · 10 known investors

Find your way into Caris Life Sciences

Sign up to see every warm intro you have to Caris Life Sciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Caris Life Sciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Caris Lifesciences operates a precision oncology platform that analyzes DNA, RNA and proteins across tissue and blood to profile a patient's cancer and match treatments and clinical trials. It offers comprehensive molecular profiling tests, including the Caris Detect multi-cancer early detection blood test, for cancer patients and physicians.

Founders & leadership

Caris Life Sciences was founded in 1996 by David Dean Halbert.

DDDavid Dean Halbert
David Dean HalbertChairman, Founder and CEO

Investors · 10

Also in the syndicate · 4

First Light Asset ManagementGhisalloPerceptive AdvisorsWoodline

Funding

SEC filings, press & company announcements

$168M disclosed across 1 round · 2025

Source: company announcements and press reports — follow each round's link for the claim.

Valuation · disclosed

Disclosed events
$5.3Bvaluation at IPOJun 2025 · $21.00/share · 424B4
filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Founder mafia

4 people who came through Caris Life Sciences went on to found or lead other companies.

Related companies · 1

Companies working in the same space as Caris Life Sciences.

In the news

Frequently asked questions

What does Caris Life Sciences do?
Caris Lifesciences operates a precision oncology platform that analyzes DNA, RNA and proteins across tissue and blood to profile a patient's cancer and match treatments and clinical trials. It offers comprehensive molecular profiling tests, including the Caris Detect multi-cancer early detection blood test, for cancer patients and physicians.
Who founded Caris Life Sciences?
Caris Life Sciences was founded by David Dean Halbert in 1996.
Who are Caris Life Sciences's investors?
Caris Life Sciences's investors include Coatue Management, Silver Lake Partners, Sixth Street, Braidwell, Millennium Management, OrbiMed.
How much funding has Caris Life Sciences raised?
Caris Life Sciences has disclosed $168M raised across 1 round.